Wednesday
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND OTHER DEVICES FOR TREATING LOWER EXTREMITY OCCLUSIVE LESIONS; RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK TREATMENTS (5- AND 4-MINUTE SHORT SUMMARY [SS] TALKS)
Location: Grand Ballroom East, 3rd Floor
Moderators:Sean P. Lyden, MD / Michael D. Dake, MD  
SESSION 26 SCHEDULE
10:25 AM - 10:30 AM Present Status And Future Potential Of DCBs: Is Durability Maintained: Preventing Restenosis And Catch-Up: Importance Of Dual Antiplatelet Agents
  Presenter(s):Gunnar Tepe, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:31 AM - 10:36 AM Best Current Treatment For Long Complex Lesions Is DCBs With Provisional Stenting: What Is The Evidence
  Presenter(s):John R. Laird, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:37 AM - 10:42 AM The REAL PTX RCT Compares DESs Versus DCBs For Treating Fempop Lesions, Some Long And Complex: At 2 Years, Results Are Better With DESs
  Presenter(s):Andrej Schmidt, MD / Yvonne Bausback, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:43 AM - 10:48 AM 5-Year Results From The IN.PACT SFA RCTs Shows Maintained Benefit Of In.Pact DCB Versus POBA For Treatment Of SFA Lesions With No Increase In Complications Or Mortality
  Presenter(s):Peter A. Schneider, MD / John R. Laird, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:49 AM - 10:54 AM The Real World GLOBAL REGISTRY Confirms The Value Of The In.Pact DCB For Treating More Complex SFA Lesions Including In Stent Restenosis (ISR)
  Presenter(s):Marianne Brodmann, MD / Gary M. Ansel, MD / Jos C. van den Berg, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:55 AM - 11:00 AM 2-Year Results Of The COMPARE PILOT RCT Comparing The Ranger DCB (Boston Scientific) With The In.Pact DCB (Medtronic) For Treating Complex Fempop Lesions And 12-Month Results Of Ranger II Trial
  Presenter(s):Dierk Scheinert, MD / Thomas Zeller, MD / Marianne Brodmann, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:01 AM - 11:06 AM Safety And Effectiveness Of The Stellarex DCB (Philips) With Low Dose Paclitaxel Up To 3 Years In The Treatment Of Fempop Occlusive Lesions
  Presenter(s):Fabrizio Fanelli, MD, EBIR / Sean P. Lyden, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:07 AM - 11:12 AM Panel Discussion
BELOW THE KNEE DCBs
11:13 AM - 11:18 AM The ACO ART II RCT Shows Favorable Results With The Orchid DCB To Treat BTK Lesions: With The Right DCB Technology The Future For BTK DCBs Is Brighter Than The Past
  Presenter(s):Francesco Liistro, MD / Wei Guo, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:19 AM - 11:24 AM Results Of A RCT Show The Lutonix DCB (Becton Dickinson/Bard) To Be Better Than POBA For BTK Occlusive Lesions
  Presenter(s):Patrick J. Geraghty, MD / Jihad A. Mustapha, MD / Marianne Brodmann, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:25 AM - 11:30 AM Value Of The Stellarex DCB (Philips) For Treating BTK Occlusive Lesions: The ILLUMINATE BTK Trial
  Presenter(s):Craig M. Walker, MD / Mahmood Razavi, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:31 AM - 11:36 AM Update On SurVeil DCBs (Surmodics/Abbott) For Treating BTK Lesions: What Makes This DCB Different: 1-Year Safety And Efficacy From The PreVail Trial
  Presenter(s):Kenneth Rosenfield, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:37 AM - 11:42 AM Economic Factors In The Treatment Of CLTI: Are Drug Coated Balloons (DCBs) DESs Stents Cost Effective: How Can The Costs Of Devices Be Met
  Presenter(s):Gary M. Ansel, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:43 AM - 11:48 AM What Is The Importance Of Dual Antiplatelet Agents To The Success Of DCBs And What Is The Current Status Of DCBs With Drugs Other Than Paclitaxel
  Presenter(s):Gunnar Tepe, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
SHORT SUMMARY 4-MINUTE TALKS
11:49 AM - 11:53 AM [SS] Value Of A Scoring Balloon (Ultrascore From Becton Dickinson/Bard) In Vessel Preparation Before DCB Use In Fempop Lesions: How It Works And Experience To Date
  Presenter(s):Marcus Thieme, MD / Dierk Scheinert, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:53 AM - 11:57 AM [SS] DEBATE: SFA Endovascular Treatment Durability Does Not Require Drug Eluting Devices: The Evidence
  Presenter(s):Lawrence A. Garcia, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:57 AM - 12:01 PM [SS] DEBATE: Not So: Drug Elution Is Essential For SFA Endovascular Treatments To Be Effective And Durable
  Presenter(s):Thomas Zeller, MD / Andrej Schmidt, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
12:01 PM - 12:06 PM Panel Discussion
12:06 PM - 1:00 PM Lunch Break 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 26
previous next